Expression of miR-142 and its relationship with Th17/Treg imbalance in children with autoimmune thyroid disease
LUO Ping, XIN Yan-Mei, GUO Qu-Lian, SHEN Xing
Department of Pediatrics, Affiliated Hospital of Southwest Medical University/Laboratory of Pediatric Hematology Oncology and Birth Defects/Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan 646000, China
Abstract：Objective To investigate the expression of microRNA-142 (miR-142) in children with autoimmune thyroid disease (AITD) and its relationship with the imbalance of helper T cell 17 (Th17) and regulatory T cell (Treg). Methods A total of 89 children hospitalized for AITD from January 2019 to December 2022 were prospectively selected as the study subjects, including 48 children with Graves' disease (GD group) and 41 children with Hashimoto's thyroiditis (HT group). Additionally, 55 healthy children undergoing physical examinations during the same period were selected as the control group. The differences in serum miR-142, antithyroglobulin antibody (TGAb), antithyroperoxidase antibody (TPOAb), Th17/Treg, and interleukin-17 (IL-17) expression were compared among the groups. Results The expression of miR-142, TPOAb, TGAb, Th17, Th17/Treg, and IL-17 in the GD group and HT group was higher than that in the control group, while Treg was lower than that in the control group (P<0.05). Pearson correlation analysis revealed that in the GD group, miR-142 was positively correlated with TPOAb, TGAb, Th17, Th17/Treg, and IL-17 (r=0.711, 0.728, 0.785, 0.716, 0.709, respectively; P<0.001) and negatively correlated with Treg (r=-0.725, P<0.001); in the HT group, miR-142 was positively correlated with TPOAb and TGAb (r=0.752, 0.717, respectively; P<0.001). Conclusions miR-142 is highly expressed in children with AITD, and its expression may be related to the Th17/Treg imbalance in children with GD.
LUO Ping,XIN Yan-Mei,GUO Qu-Lian et al. Expression of miR-142 and its relationship with Th17/Treg imbalance in children with autoimmune thyroid disease[J]. CJCP, 2024, 26(6): 605-610.
Wang Y, Fang S, Zhou H. Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms[J]. Best Pract Res Clin Endocrinol Metab, 2023, 37(2): 101743. PMID: 36841747. DOI: 10.1016/j.beem.2023.101743.
Chen A, Huang L, Zhang L. Helper T cell 17 and regulatory T cell levels in peripheral blood of newly diagnosed patients with autoimmune thyroid disease: a meta-analysis[J]. Horm Metab Res, 2023, 55(1): 40-50. PMID: 36332627. DOI: 10.1055/a-1972-5787.
Cao Y, Jin X, Sun Y, et al. Therapeutic effect of mesenchymal stem cell on Hashimoto's thyroiditis in a rat model by modulating Th17/Treg cell balance[J]. Autoimmunity, 2020, 53(1): 35-45. PMID: 31793369. DOI: 10.1080/08916934.2019.1697689.
Liu HY, Shi ZY, Fan D, et al. Absolute reduction in peripheral regulatory T cells in patients with Graves' disease and post-treatment recovery[J]. Mol Immunol, 2022, 144: 49-57. PMID: 35189399. DOI: 10.1016/j.molimm.2022.02.004.
Bayomy NR, Abo Alfottoh WM, Ali Eldeep SA, et al. Mir-142-5p as an indicator of autoimmune processes in childhood idiopathic nephrotic syndrome and as a part of microRNAs expression panels for its diagnosis and prediction of response to steroid treatment[J]. Mol Immunol, 2022, 141: 21-32. PMID: 34785326. DOI: 10.1016/j.molimm.2021.11.004.
De Vito F, Musella A, Fresegna D, et al. MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis[J]. Neuropathol Appl Neurobiol, 2022, 48(2): e12765. PMID: 34490928. PMCID: PMC9291627. DOI: 10.1111/nan.12765.
Li G, He L, Huang J, et al. miR-142-3p encapsulated in T lymphocyte-derived tissue small extracellular vesicles induces Treg function defect and thyrocyte destruction in Hashimoto's thyroiditis[J]. BMC Med, 2023, 21(1): 206. PMID: 37280674. PMCID: PMC10242775. DOI: 10.1186/s12916-023-02914-7.
